The U.S Food and Drug Administration (FDA) recently issued a warning letter to dietary supplement manufacturer EuroPharma, Inc., stating that because the company’s Web site contains links to articles with health benefit claims, FDA considers the products to be drugs. EuroPharma reportedly disputed the alleged claims, stating that the articles were separated by a disclaimer, but according to FDA, “The therapeutic claims on your web site establish that these products are drugs because they are intended for use in the cure, mitigation, treatment, or prevention of disease . . . and the marketing of these products with these claims violates the [Federal Food, Drug, and Cosmetic] Act.”